Mario Schlosser Sells 31,422 Shares of Oscar Health (NYSE:OSCR) Stock

Oscar Health, Inc. (NYSE:OSCR) Director Mario Schlosser sold 31,422 shares of the firm’s stock in a transaction on Thursday, September 3rd. The stock was sold at an average price of $31.45, for a total transaction of $988,221.90. Following the completion of the transaction, the director directly owned 449,444 shares of the company’s stock, valued at approximately $14,135,013.80. This represents a 6.53% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Mario Schlosser also recently made the following trade(s):

• On Friday, August 28th, Mario Schlosser sold 150,000 shares of Oscar Health stock. The shares were sold at an average price of $30.79, for a total transaction of $4,618,500.00.
• On Thursday, August 27th, Mario Schlosser sold 600,000 shares of Oscar Health stock. The shares were sold at an average price of $30.34, for a total value of $18,204,000.00.
• On Tuesday, June 23rd, Mario Schlosser sold 147,500 shares of Oscar Health stock. The shares were sold at an average price of $29.38, for a total value of $4,333,550.00.
• On Tuesday, June 23rd, Mario Schlosser sold 880,000 shares of Oscar Health stock. The stock was sold at an average price of $29.38, for a total value of $25,854,400.00.

Oscar Health Stock Performance

OSCR traded up $0.65 on Tuesday, reaching $32.90. 4,754,751 shares of the stock were exchanged, compared to its average volume of 7,062,275. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.09 and a quick ratio of 1.09. The company’s 50-day moving average price is $30.49 and its 200 day moving average price is $22.87. The firm has a market capitalization of $10.15 billion, a PE ratio of 23.50, a PEG ratio of 0.66 and a beta of 2.37. Oscar Health, Inc. has a fifty-two week low of $10.69 and a fifty-two week high of $33.55.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings data on Thursday, August 6th. The company reported $1.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.70. Oscar Health had a return on equity of 38.45% and a net margin of 3.60%.The firm had revenue of $4.88 billion during the quarter, compared to analysts’ expectations of $4.73 billion. During the same period last year, the business posted ($0.89) earnings per share. The company’s revenue for the quarter was up 70.4% compared to the same quarter last year. As a group, sell-side analysts forecast that Oscar Health, Inc. will post 1.54 EPS for the current fiscal year.

Institutional Trading of Oscar Health

A number of hedge funds have recently added to or reduced their stakes in the company. CoreCap Advisors LLC increased its holdings in Oscar Health by 526.3% in the second quarter. CoreCap Advisors LLC now owns 1,190 shares of the company’s stock valued at $34,000 after buying an additional 1,000 shares in the last quarter. GAMMA Investing LLC boosted its stake in shares of Oscar Health by 32.9% during the 2nd quarter. GAMMA Investing LLC now owns 1,441 shares of the company’s stock worth $41,000 after acquiring an additional 357 shares in the last quarter. Quarry LP grew its position in shares of Oscar Health by 439.8% during the 3rd quarter. Quarry LP now owns 1,803 shares of the company’s stock valued at $34,000 after acquiring an additional 1,469 shares during the period. FNY Investment Advisers LLC purchased a new position in shares of Oscar Health in the 2nd quarter valued at about $57,000. Finally, Jones Financial Companies Lllp boosted its position in Oscar Health by 7,473.3% during the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after purchasing an additional 2,242 shares in the last quarter. 75.70% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several brokerages have commented on OSCR. Wells Fargo & Company lifted their price objective on shares of Oscar Health from $20.00 to $27.00 and gave the company an “equal weight” rating in a research note on Thursday, August 13th. Weiss Ratings upgraded shares of Oscar Health from a “sell (d+)” rating to a “hold (c+)” rating in a research note on Tuesday, August 11th. UBS Group raised their target price on shares of Oscar Health from $20.00 to $26.00 and gave the stock a “neutral” rating in a report on Friday, August 7th. Robert W. Baird set a $27.00 target price on shares of Oscar Health in a research report on Friday, August 7th. Finally, Piper Sandler reaffirmed an “overweight” rating and issued a $36.00 price target on shares of Oscar Health in a report on Tuesday, July 28th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $26.22.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.